Brind.

MannKind Corporation focused on the U.S. market for pharmaceuticals in July 2025.

1 report, 1 independent Updated Jul 15

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

MannKind Corporation

How it developed

Newest first. Tap a step to see who reported it.

Jun 8Wells Fargo gave a Buy rating on MannKind Corporation on July 11, 2025.Sub-event
Jul 15The company highlighted its focus on the U.S. pharmaceutical market.1 source
- Simply Wall St.

Keep exploring

The entities involved

MannKind Corporation
biopharmaceutical company
- MannKind Corporation stock trades on the Nasdaq electronic exchange, with market data reported by MarketBeat.Thu 18:09

Related events

MannKind Corporation (or its related entity, MeiraGTx Holdings PLC) listed on the electronic stock exchange on September 1, 2026.Sep 7

Coverage

Newest first; wire copies grouped

Jul 15Simply Wall St.High Growth Tech Stocks To Watch In The US July 2025 As the United States market navigates a complex landscape marked by trade policy uncertainties and fluctuating economic indicators, major indices